Immune Complex
About Immune Complex
Immune Complex Corporation (ICC), founded in 1994, focuses on the development of vaccines for infectious diseases based on its proprietary antigen delivery platform, CorVax(TM). ICC's first vaccine candidate based on this delivery platform, MalariVax(TM), is scheduled to enter Phase I clinical trials in 2001.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/immune-complex-561557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.